Evidence Summary
- Evidence Level
- Preliminary
- Mechanism
- Antiviral / Persistence, Enrollment: Actual, Sponsor Type: Other, Unknown / General
- Safety
- Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
- Dosing
- See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 3 associated trial(s) and 0 study reference(s) in current data. Review primary sources and consult specialists before use.
Clinical Trials
3 trial(s) registered
| NCT ID | Title | Phase | Status |
|---|---|---|---|
| NCT05965726 | RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms | Phase 2 | Completed |
| NCT05576662 | Paxlovid for Treatment of Long Covid | Phase 2 | Completed |
| NCT05668091 | A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults with Long COVID. | Phase 2 | Completed |
Key Studies / References
- See linked studies